台灣先進醫學科技股份有限公司

內頁主視覺
Home / Information / News

News

2020/04/14

COVID-19 coronavirus will led to Idiopathic Pulmonary Fibrosis, IPF, nebulizer can help!

Do you know COVID-19 will cause pulmonary fibrosis; it needs medical treatment for life!
If it is a 20-30-year-old young man, then lung fibrosis be recovered can reach 70-80% or even 90%,
If the age is 50 to 60-year-old, then only 50% of lung fibrosis can be recovered.

According to the actual clinical situation, after the first diagnosis of new COVID-19 in Taiwan was cured, the pulmonary fibrosis was indeed found by radiation computed tomography (CT).
A new study from North Carolina State University shows that lung stem cell secretions -- specifically exosomes and secretum's -- delivered via nebulizer, can help repair(mend) lung injuries due to multiple types of pulmonary fibrosis in mice and rats. The work could lead to more effective, less invasive treatment for human pulmonary fibrosis sufferers.
And Zhang Yiwen, Ph.D. of Yangming Biochemical Institute, which specializes in cell technology, said that he recently published a study in the top international journal Nature Communications. The delivery of lung stem cell secretions can help mice and rats repair(mend) lung damage caused by pulmonary fibrosis, providing a potentially noninvasive treatment for patients with pulmonary fibrosis.

In addition, 
if you want to use a nebulizer to soothe the lungs, the non-medical certified nebulizer or beauty sprayer on the market is "not allowed" as a medical device to pour the liquid into the spray!

Reference: 
1.Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048814/
2. Dciencedaily : https://www.sciencedaily.com/releases/2020/02/200228073026.htm